3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Sexual Dysfunction, Physiological
3
Obesity
3
Infertility
3
Depression
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Leukemia, Myeloid, Acute
2
Hodgkin Disease
2
Congenital Abnormalities
2
Colonic Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Sleep Wake Disorders
1
Sezary Syndrome
1
Sexuality
1
Sarcoma, Kaposi
1
Sarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Osteosarcoma
1
Nutrition Disorders
1
Neoplasms, Germ Cell and Embryonal
1
Mycosis Fungoides
1
Mucositis
1
Motor Activity
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Interventions
Nutrition Assessment
3
Urine Specimen Collection
1
Therapeutics
1
Resistance Training
1
Observation
1
Holistic Health
1
Electrocardiography
1
Blood Specimen Collection
1
Biopsy
1
Adrenalectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypertension
×
Therapeutics
×
Other
×
Clear all
NCT03443635
2022-04-29
CHOP
Tulane University
Phase 1/2
Completed
7,192 enrolled
7 charts